cbdMD Inc. announced it has entered into Securities Purchase Agreements with four institutional investors, issuing a total of 1,700,000 shares of Series B Convertible Preferred Stock for aggregate gross proceeds of $1,700,000 ($1.00 per share). Net proceeds of $1,500,000 will be used for working capital. The shares are convertible into common stock and accrue a 10% annual dividend.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. cbdMD Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001437749-25-030537), on October 06, 2025, and is solely responsible for the information contained therein.